Search

everythinglearnresearchcommunity

for

Search:↓

Extended-release valproate effectively reduced seizures and improved quality of life in epilepsy patients over 6 months, with some side effects.

Fulvestrant at 10 mg/kg does not promote hair regrowth in dogs with alopecia X.

Dupilumab helps children with alopecia areata regrow hair safely.

New compounds may help treat prostate cancer by reducing cell growth.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

PPCM microspheres can effectively release finasteride over 42 days.

PRP treatment can safely boost hormone levels in some IVF patients with low ovarian reserve.

Men with early-onset hair loss are less responsive to bromocriptine's heart and metabolism benefits.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Hyperprolactinemia is the most common cause of secondary amenorrhea, followed by drug use.

The conclusion is that future trials should report specific details about the PRP composition to better understand its effects on urologic conditions.

Sebaceous glands in the skin play a key role in absorbing the antiandrogen drug RU 58841, especially when it's encapsulated in liposomes.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

RU 58841 may treat acne, hair loss, and excessive hair growth.

The combination therapy effectively treats infertility in PCOS without major side effects.

Dupilumab helped an 11-year-old boy regrow hair and reduce skin rashes.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

The F9 formulation of Finasteride tablets, using Eudragit, successfully controlled drug release.

Men with low testosterone should be carefully evaluated and monitored before and during treatment.

A reliable method was developed to measure dutasteride in tablets accurately and consistently.

The patient was satisfied with hormone therapy, and her epilepsy remained stable.